12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Global Genomics Group, Health Diagnostic Laboratory, Metabolon deal

Metabolon will measure and interpret concentrations of biochemicals and metabolites using its TrueVision metabolomics platform and targeted assays in the ongoing, prospective, international GLOBAL study to determine candidate genes and markers underlying coronary artery disease (CAD). Global...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >